Press releases

To stay up to date with our development, sign up for a subscription.

Subscribe

Exercise of the overallotment option

Regulatory

Pareto Securities has notified Sedana Medical AB (publ) (”Sedana Medical” or the ”Company”), that the overallotment option has been exercised in full.

Sedana Medical AB (publ) launches AnaConDa-S

Non-regulatory

Sedana Medical AB (publ) ("Sedana Medical" or "the Company") is launching AnaConDa-S, a new innovation and an enhancement of its predecessor AnaConDa, in which the ‘dead volume’ has been halved from 100 ml to 50 ml. Halving the dead volume increases…

Sedana Medical AB (publ) registers AnaConDa in South Korea

Non-regulatory

Sedana Medical AB’s (publ) (“Sedana Medical” or " the Company") product AnaConDa is approved by K-FDA in South Korea. South Korea is the first country in Asia to approve AnaConDa. The product will be launched in cooperation with the distributor DaeSe…

Christer Ahlberg new CEO of Sedana Medical AB (publ)

Non-regulatory

The Board of Directors of Sedana Medical AB (publ) ("Sedana Medical" or "the Company") has appointed Christer Ahlberg as new CEO for the Company and the group. Christer Ahlberg succeeds Mike Ryan, who will focus on board management inside and outside…